Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas. Chiba M, Shimono J, Ishio T, Takei N, et al. Blood 2022;140:1951-1963.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chiba M, Shimono J, Ishio T, Takei N, et al. Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas. Blood 2022;140:1951-1963.
PMID: 35921533